ScripBiotech initial public offerings in Europe have been as rare as hen’s teeth in the past few years so the news that Swiss antibiotics specialist BioVersys is looking to list has caught the eye. The Bas
Medtech InsightCinclus Pharma and Implantica, a duo of Swedish companies, are working to create new therapies for gastroesophageal reflux disease (GERD) but are approaching the problem from opposite ends of the hea